PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

imminent means, page-19

  1. 4,262 Posts.
    lightbulb Created with Sketch. 6757
    A glutton for punishment? Perhaps
    Tad over optimistic for the short term future? Maybe, slightly.




    Nervous? Not a bit, still sleeping well at night.



    I know what our drug can do, I believe in what it's worth. Will others? I reckon eventually when they know we are closer to the P3 gold-like data we have already seen in very similar studies to date.

    Will they pay? I should think so...they will understand what an eventual revenue spinner this will be...they will understand and be able to forecast the uptake rates, the insurance rebates and the (many) other future indications other than OA that this is applicable to. They like me, will not use the 65% penetration achievement of DMARD drugs that are fatal in a lot of cases.


    5% uptake sliver is plenty





    My thoughts


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.